Stock 003020 HEFEI LIFEON PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hefei Lifeon Pharmaceutical Co., Ltd.

Equities

003020

CNE100004BD9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
23.46 CNY -1.01% Intraday chart for Hefei Lifeon Pharmaceutical Co., Ltd. -7.71% -16.66%
Apr. 29 Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Hefei Lifeon Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 4,248 3,956 4,495 3,745 -
Enterprise Value (EV) 1 4,248 3,956 4,495 3,745 3,745
P/E ratio 24.7 x 18.6 x 19.8 x 13.2 x 11.1 x
Yield - 1.55% 1.78% 2.28% 2.49%
Capitalization / Revenue - 1.53 x 2.36 x 2.47 x 2.06 x
EV / Revenue - 1.53 x 2.36 x 2.47 x 2.06 x
EV / EBITDA - 16.3 x 15.3 x 9.99 x 8.55 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 2.67 x 2.67 x 2 x 1.77 x
Nbr of stocks (in thousands) 156,562 159,207 159,675 159,643 -
Reference price 2 27.14 24.85 28.15 23.46 23.46
Announcement Date 4/18/22 4/17/23 4/22/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 2,579 1,901 1,519 1,822
EBITDA 1 - 242.4 293.3 375 438
EBIT 1 - 240.1 255.3 331.5 392
Operating Margin - 9.31% 13.43% 21.82% 21.52%
Earnings before Tax (EBT) 1 - 239.8 257.4 332 392
Net income 1 172.2 209.6 226.7 284.5 335.5
Net margin - 8.13% 11.93% 18.73% 18.42%
EPS 2 1.101 1.338 1.420 1.780 2.105
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - 0.3846 0.5000 0.5350 0.5850
Announcement Date 4/18/22 4/17/23 4/22/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 15.1% 14.4% 15.7% 16.3%
ROA (Net income/ Total Assets) - 11% - 14.4% 14.9%
Assets 1 - 1,898 - 1,976 2,252
Book Value Per Share 2 - 9.300 10.60 11.70 13.30
Cash Flow per Share 2 - 1.260 1.280 2.520 2.400
Capex 1 - 246 197 50 50
Capex / Sales - 9.54% 10.39% 3.29% 2.74%
Announcement Date 4/18/22 4/17/23 4/22/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hefei Lifeon Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.46
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HEFEI LIFEON PHARMACEUTICAL CO., LTD. Stock Hefei Lifeon Pharmaceutical Co., Ltd.
-16.66% 524M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 003020 Stock
  4. Financials Hefei Lifeon Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW